EASL schedules press conference and news briefings during International Liver Congress 2011

The EASL International Liver Congress is an opportunity for over 6,000 clinicians and scientists from around the world to hear the latest research, perspectives and treatments for liver diseases from principal experts in the field. It features a high-calibre and multi-disciplinary scientific programme covering groundbreaking information and in-depth examination of the most essential topics.

EASL will hold an international press conference and two morning news briefings during its International Liver Congress 2011 in Berlin.

EASL Press Conference

Date: Thursday 31st March 2011
Time: 11:00am - 12:00am
Location: Room 43

Leading experts will highlight new developments in the future management of viral hepatitis C. A question and answer session will follow the presentations.

Speakers will also be available for informal discussions and interviews following the presentations.

Due to limited space, please confirm your attendance at the press conference with the EASL press office now.

Morning News Briefings

To ensure you get the best out of ILC, news briefings will be held to provide you with the latest news and data on the following topics

Friday 1st April - Liver transplantation & Wilson's disease
Saturday 2nd April 2011 - Hepatocellular carcinoma & Fatty liver disease

Times: 8:00am - 8:45am
Location: The Press Centre

Onsite Press Office staff will be able to assist you in organising interviews with the relevant experts. Wi-Fi access will be available in the press working room.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
UAB researchers reverse liver disease in mice with gene therapy